From: IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation
group | NC | CHB | HBV-ACLF |
---|---|---|---|
case | 16 | 31 | 13 |
sex(M/F) | 12/4 | 25/6 | 12/1 |
age(years) | 29.5(26-63) | 36(21-61) | 44(37-67) |
ALT(U/L) | 21.5(11-34) | 50(11-217) | 90(46-245) |
AST(U/L) | 22(12-34) | 46(21-222) | 117(58-158) |
Tbil(umol/L) | ND | 12.6(4.0-119.9) | 473.8(51.9-720) |
INR | ND | 1.04(0.88-1.23) | 2.87(2.01-4.68) |
PTA(%) | ND | 94(72-128) | 26(16-39) |
Log10 (HBV DNA) | ND | 5.17(1.30-8.23) | 3.25(1.51-8.19) |
HBsAg-positive | 0 | 31 | 13 |
HBsAb-positive | 16 | 0 | 0 |
HBeAg-positive | 0 | 13 | 3 |
HBeAb-positive | 0 | 18 | 10 |
HBcA-bpositive | 0 | 31 | 13 |
MELD score | ND | ND | 28.2±1.22 |